Unterschiede

Hier werden die Unterschiede zwischen zwei Versionen angezeigt.

--- hedera_helix_l [2015/03/16 09:54] – andreas
+++ hedera_helix_l [2024/12/27 09:37] (aktuell) – andreas
@@ Zeile 9: / Zeile 9: @@
 [[http://en.wikipedia.org/wiki/Hedera_helix]]
-"Phytochemical analysis of ivy can comprise a wide range of compounds such as bidesmodic triterpene saponines (e.g.hederacoside C, α-hederine), volatile oil (e.g. methylethylketone), polyines (e.g. falcarinol), steroids (e.g. β-sitosterol), phenols (e.g. rosmarinic acid), and flavonoids (e.g. rutin)... \\
+"Phytochemical analysis of ivy can comprise a wide range of compounds such as bidesmodic triterpene saponines (e.g.hederacoside C, α-hederin), volatile oil (e.g. methylethylketone), polyines (e.g. falcarinol), steroids (e.g. β-sitosterol), phenols (e.g. rosmarinic acid), and flavonoids (e.g. rutin)... \\
 α-Hederin amounts in younger flowering branch leaves were remarkably higher than in older ones, in B2, [it] was found in 1.62% whereas in B1 it was only 0.18%. Non-flowering branch leaves (B3) contained hederacoside C in 6.53%, which was found in flowering branch leaves (B1) in 4.72% amount, α-hederin was not detected in B3." \\
 [HPLC profiling and quantification of active principles in leaves of Hedera helix L., Demirci, B., Goppel, M., Demirci, F., Franz, G., Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol.59(10), 2004, 770-774]
@@ Zeile 16: / Zeile 16: @@
 During a 16-year period from May 1993 to May 2009, 127 persons, including controls, were patch tested with falcarinol and 10 tested positive."
 [Dermatitis from common ivy (Hedera helix L. subsp. helix) in Europe: past, present, and future., Paulsen, E., Christensen, L.P., Andersen, K.E., Contact dermatitis, Vol.62(4), 2010, 201-209]
+{{:h_genin.jpg|}} α-hederin (R1=Rha1->2Ara-; R2=CH2OH); β-hederin (R1=6-deoxy-Man2->3Ara-; R2=CH3)
 "Preparations of ivy leaves dry extract with secretolytic and bronchiolytic efficacy are widely used for the treatment of acute and chronic obstructive airway diseases. The mechanism by which ivy preparations improve lung functions is not fully understood. Here, we tested the influence of the three main saponins of ivy, α-hederin, hederacoside C and hederagenin, on the contraction and relaxation behaviour of isolated bovine tracheal smooth muscle strips by isometric tension measurements. None of the tested compounds altered histamine or methacholine-induced contraction of the smooth muscle strips. In contrast, the isoprenaline-induced relaxation of 100 μM methacholine precontracted muscle strips was significantly enhanced when pre-treated with 1 μM of α-hederin for 18 h. The pre-treatment with hederacoside C or hederagenin had no effect on isoprenaline-induced relaxation. For the first time the bronchiolytic effect of α-hederin was demonstrated by isometric tension measurements using bovine tracheal smooth muscle strips. α-Hederin increases isoprenaline-induced relaxation indirectly, probably by inhibiting heterologous desensitization induced by high concentrations of muscarinic ligands like methacholine." \\
@@ Zeile 27: / Zeile 29: @@
 [[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3719157/]]
-"The effect of ivy leaves dry extract is based on its secretolytical and broncholytical properties. The main active compounds are saponins (Cioacá et al., 1978, Trute et al., 1997 and Bedir et al., 2000), especially alpha-hederin represents the most important saponin molecule responsible for the therapeutic effect (Sieben et al. 2009). Alpha-hederin inhibits the internalization of the β2-receptor leading to an increased adrenergic accessibility of the cells. Subsequently, type II alveolar epithelial cells generate more surfactant yielding to the secretolytic activity by reduction of the mucus viscosity. Similarly, the bronchodilating effect can be related to the increased β2-adrenergic activity resulting in a higher sensitivity to spasmolytics such as adrenalin, the strongest physiological bronchodilator (Hegener et al. 2004). In a double blind comparative study against Ambroxol, the ivy leaves dry extract demonstrated non-inferiority concerning relevant clinical and lung function outcome parameters (Meyer-Wegener et al. 1993). \\
+"The effect of ivy leaves dry extract is based on its secretolytical and broncholytical properties. The main active compounds are saponins (Cioacá et al., 1978, Trute et al., 1997 and Bedir et al., 2000), especially α-hederin represents the most important saponin molecule responsible for the therapeutic effect (Sieben et al. 2009). α-Hederin inhibits the internalization of the β2-receptor leading to an increased adrenergic accessibility of the cells. Subsequently, type II alveolar epithelial cells generate more surfactant yielding to the secretolytic activity by reduction of the mucus viscosity. Similarly, the bronchodilating effect can be related to the increased β2-adrenergic activity resulting in a higher sensitivity to spasmolytics such as adrenalin, the strongest physiological bronchodilator (Hegener et al. 2004). In a double blind comparative study against Ambroxol, the ivy leaves dry extract demonstrated non-inferiority concerning relevant clinical and lung function outcome parameters (Meyer-Wegener et al. 1993). \\
 ... children with mild uncontrolled asthma despite regular inhaled corticosteroid therapy might benefit from an additional therapy with ivy leaves dry extract. However, further studies are needed." \\
 [Tolerance and effect of an add-on treatment with a cough medicine containing ivy leaves dry extract on lung function in children with bronchial asthma., Zeil, S., Schwanebeck, U., Vogelberg, C., Phytomedicine, Vol.21(10), 2014, 1216-1220] \\
 [[http://www.sciencedirect.com/science/article/pii/S094471131400227X]]
-{{:efeu.jpg?500}} \\
+"The bronchospasmolytic and secretolytic effects of ivy leaves dry extracts can be explained by an increased β2-adrenergic responsiveness of the bronchi. Recently, it was shown that α-hederin inhibits the internalization of β2-adrenergic receptors (ß2AR) under stimulating conditions. α-Hederin pretreated alveolar type II cells and human airway smooth muscle cells revealed an increased ß2AR binding and an elevated intracellular cAMP level, respectively...\\
-Lindman, C.A.M., Bilder ur Nordens Flora, vol.2, t.249 (1922-1926) \\
+In order to identify whether additional compounds also mediate an increased β2-adrenergic responsiveness, we examined the ingredients of an ivy leaves dry extract (EA 575) protocatechuic acid, neochlorogenic acid, chlorogenic acid, cryptochlorogenic acid, rutin, kaempferol-3-O-rutinoside, 3,4-, 3,5- and 4,5-dicaffeoylquinic acid, hederacoside B, and β-hederin. Within all the tested substances, only β-hederin inhibited the internalization of GFP-tagged ß2AR in stably transfected HEK293 cells. Using fluorescence correlation spectroscopy β-hederin (1 μM, 24 h) pretreated HASM cells showed a statistically significant increase in the ß2AR binding... Within this systematic study focusing on the influence of the ingredients of an ivy leaves dry extract on HASM cells it was possible to identify β-hederin as further component presumably responsible for the β2-mimetic effects." \\
-[[http://plantgenera.org/species.php?id_species=496846]]
+[A systematic study on the influence of the main ingredients of an ivy leaves dry extract on the β 2-adrenergic responsiveness of human airway smooth muscle cells., Greunke, C., Hage-Hülsmann, A., Sorkalla, T., Keksel, N., Häberlein, F., Häberlein, H., Pulmonary pharmacology & therapeutics, 2014] \\
+[[http://www.sciencedirect.com/science/article/pii/S1094553914001114]]
+"... hederagenin has been shown to possess anti-nociceptive and anti-inflammatory properties in mice, and ivy extracts are commonly used in natural medicine to treat rheumatoid arthritis... [hederagenin is] a novel and selective antagonist at the NPFFR1. Through comprehensive analysis, its binding mode at the NPFFR1 and critical residues that contribute to the selectivity of the antagonist over NPFFR2 have been determined." \\
+[Lentschat, Hannah, et al. "Hederagenin is a Highly Selective Antagonist of the Neuropeptide FF Receptor 1 that Reveals Mechanisms for Subtype Selectivity." Angewandte Chemie (2024): e202417786]
+{{:efeu.jpg?600}} \\
+[[http://plantgenera.org/species.php?id_species=496846|Lindman, C.A.M., Bilder ur Nordens Flora, vol.2, t.249 (1922-1926)]]
+{{:dsc01031k.jpg}} \\
+Hedera helix leaves [[https://creativecommons.org/licenses/by-sa/3.0/de/|CC BY-SA 3.0]], Author: Andreas Kraska
-{{:dsc01031k.jpg?800|}}